Param Immuno-Veda Private Limited - Company Profile

It is a healthcare private limited company based in Nashik, Maharashtra, India, established in 2011.
2011 Nashik, Maharashtra, India Struck Off
Last Updated:
Access Report
About Param Immuno-Veda Private Limited

Param Immuno-Veda Private Limited, a struck off private limited company, was established on 23 June 2011 in Nashik, Maharashtra, India. Engaging in human health activities within the healthcare sector, it holds CIN: U85100MH2011PTC218999. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Mahesh Shankarrao Patil (Director), Rakesh Shankarrao Patil (Director), Paresh Ramesh Dange (Director). It is based at 1/3, Yashprabha Society, Patil Lane No.2, College Road, Nashik, Maharashtra, 422005.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U85100MH2011PTC218999

  • Registration Number

    218999

  • Incorporation Date

    23 June 2011

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 14 Year, 9 Months
Company report

Param Immuno-Veda Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Param Immuno-Veda Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Param Immuno-Veda Private Limited?
Current Directors
Name Designation Appointment Date Status
Mahesh Shankarrao Patil Director 23 Jun 2011 Current
Rakesh Shankarrao Patil Director 23 Jun 2011 Current
Paresh Ramesh Dange Director 23 Jun 2011 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Param Immuno-Veda.

Enhance accessibility to Param Immuno-Veda's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Param Immuno-Veda revenue growth over time
Param Immuno-Veda profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Param Immuno-Veda?

Unlock access to Param Immuno-Veda's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Param Immuno-Veda?

Unlock and access historical data on people associated with Param Immuno-Veda, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Param Immuno-Veda, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Param Immuno-Veda's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Param Immuno-Veda
Recent Activity within the Organization
  • Director Appointment

    Progress on Mahesh Shankarrao Patil was appointed as a Director was appointed as a Director on 23 Jun 2011 & has been associated with this company since 14 years 9 months . was documented.

  • Director Appointment

    Rakesh Shankarrao Patil was appointed as a Director was appointed as a Director on 23 Jun 2011 & has been associated with this company since 14 years 9 months . was recorded as a recent event.

  • Director Appointment

    Paresh Ramesh Dange was appointed as a Director was appointed as a Director on 23 Jun 2011 & has been associated with this company since 14 years 9 months . was recorded as a recent event.

  • Company Incorporation

    The activity Param Immuno-Veda Private Limited was registered on 23 Jun 2011 with Roc Mumbai & aged 14 years 9 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Param Immuno-Veda Private Limited?

The CIN of Param Immuno-Veda Private Limited is U85100MH2011PTC218999.

Where is Param Immuno-Veda Private Limited headquartered?

Param Immuno-Veda Private Limited is headquartered at 1/3, Yashprabha Society, Patil Lane No.2, College Road, Nashik, Maharashtra, 422005.

When was Param Immuno-Veda Private Limited incorporated?

Param Immuno-Veda Private Limited was incorporated on 23 June 2011.

Who are the current directors of Param Immuno-Veda Private Limited?

The current directors of Param Immuno-Veda Private Limited are

What is the primary industry of Param Immuno-Veda Private Limited?

The primary industry of Param Immuno-Veda Private Limited is Healthcare.

Is Param Immuno-Veda Private Limited a listed company?

Param Immuno-Veda Private Limited is unlisted.

What is the capital structure of Param Immuno-Veda Private Limited?

The authorized capital of Param Immuno-Veda Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available